Brief: Galecto To Collaborate With Roche For Phase 2 Trial Of Lung Cancer Treatment

Damora Therapeutics

02/11/2021 13:07

Nov 2 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO ANNOUNCES CLINICAL COLLABORATION WITH ROCHE FOR
PHASE 2
TRIAL OF GB1211 IN COMBINATION WITH ATEZOLIZUMAB IN FIRST LINE
NON-SMALL-CELL LUNG CANCER
    * GALECTO INC - UNDER TERMS OF AGREEMENT, GALECTO WILL FUND
AND
CONDUCT A PHASE 2A CLINICAL TRIAL TO INVESTIGATE COMBINATION OF
GB1211
    * GALECTO - LOOK FORWARD TO INITIATING PHASE 2A COMBINATION
STUDY
OF GB1211 IN NSCLC DURING 1ST HALF OF 2022 & ANTICIPATE TOPLINE
DATA FROM TRIAL IN MID-2023

Source text for Eikon:  ID:nGNX6NXyW5 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))